Laboratory Equipment · Genomics & Genetic Testing
PacBio revenue, results and funding
PacBio filed revenue of $160M for 2025.
Data updated Nov 19, 2026 · Back to the company report
$160MRevenue, 2025
−$546.4MNet income, 2025
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_BUYBACKS | LANG_CR_S_M_CAPEX | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT | LANG_CR_S_M_ACQUISITIONS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $160M | −$546.4M | $784.1M | $481k | $318k | – | $2.7M | $41.7M | $97.3M | −$553.9M | $63.7M | – | $0 |
| 2024 | $154M | −$309.9M | $1.3B | $256k | $316k | – | $6.2M | $71M | $134.9M | −$474.3M | $55.4M | – | $0 |
| 2023 | $200.5M | −$306.7M | $1.7B | $140k | −$11.4M | – | $8.8M | $72.1M | $187.2M | −$334.5M | $179.9M | – | $102k |
| 2022 | $128.3M | −$314.2M | $1.8B | – | $0 | – | $16.8M | $78.6M | $193M | −$307.2M | $325.1M | $896.7M | $0 |
| 2021 | $130.5M | −$181.2M | $2B | – | −$93.6M | – | $5.9M | $73.4M | $112.9M | −$210.4M | $460.7M | $896.1M | – |
| 2020 | $78.9M | $29.4M | $414M | – | – | – | $1M | $17.5M | $64.2M | −$104.4M | $81.6M | – | – |
| 2019 | $90.9M | −$84.1M | $148M | – | – | – | $2.8M | $16.4M | $59.6M | −$100.5M | $29.6M | $15.9M | – |
| 2018 | $78.6M | −$102.6M | $170.3M | – | – | – | $1.9M | $23.2M | $62.6M | −$101M | $18.8M | $14.7M | – |
| 2017 | $93.5M | −$92.2M | $144.1M | – | – | – | $10.4M | $20.4M | $65.3M | −$89.8M | $16.5M | $13.6M | – |
| 2016 | $90.7M | −$74.4M | $137.9M | – | – | – | $8.2M | $19.6M | $67.6M | −$71.2M | $16.8M | $16.1M | – |
| 2015 | $92.8M | −$31.7M | $131.1M | – | – | – | $3M | $13.8M | $60.4M | −$29.1M | $33.6M | – | – |
| 2014 | $60.6M | −$66.2M | $124.4M | – | – | – | $1.6M | $9.9M | $48.2M | −$62.9M | $36.4M | $14.1M | – |
| 2013 | $28.2M | −$79.3M | $136.2M | – | – | – | $909k | $9.9M | $45.2M | −$77.5M | $26.4M | $13.3M | – |
| 2012 | $26M | −$94.5M | $129.7M | – | – | – | $1.7M | $9.7M | $47.6M | −$94.3M | $46.5M | $2.6M | – |
| 2011 | $33.9M | −$109.4M | $218.3M | – | – | – | $9.3M | $12.4M | $76.1M | −$109.8M | $58.9M | $2.8M | – |
Sources: SEC
How to cite
PacBio, Financials. Alion, Nov 19, 2026. https://alion.io/company/pacbio/financials
